Each treatment regimen has advantages and disadvantages (Table 1), and these should be taken into account when deciding on a strategy with the patient
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors
References Frias JP, et al
Melanin helps to protect the skin against damaging ultraviolet (UV) light from the sun, which is why skin can darken following exposure to UV
The first oral tirzepatide-class medication
According to CareEdge Ratings, Indias potential GLP-1 market is set to expand nearly five-fold from 1,000 crore to 1,200 crore in 2025 to approximately 4,500 crore to 5,000 crore by 2030